Modulation of inflammatory mediators by coumarinolignoids from Cleome viscosa in female swiss albino mice

Inflammopharmacology

Volumn 16, Issue 6, 2008, Pages 272-277

  Bawankule, D U ^a   Chattopadhyay, S K ^a   Pal, A ^a   Saxena, K ^a   Yadav, S ^a   Faridi, U ^a   Darokar, M P ^a   Gupta, A K ^a   Khanuja, S P S ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Coumarinolignoids; Inflammation; Macrophages; Mice; Spleenocytes

Indexed keywords

AUTACOID; CLEOMISCOSIN A; CLEOMISCOSIN B; CLEOMISCOSIN C; CONCANAVALIN A; COUMARIN DERIVATIVE; COUMARINOLIGNOID; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLEOME; CLEOME VISCOSA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG MIXTURE; FEMALE; INBRED STRAIN; INFLAMMATION; MEDIATOR; MOUSE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 58149141382     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-008-8012-0     Document Type: Article

References (38)

1. Asolkar, L. V., Kakkar, K. K., Chakre, O. J. (1992). Second supplement to Glossary of Indian medicinal plants with active principles part I (A-K), PID, Dr. K. S. Krishnan Marg, New Delhi 1965-1981, 217.
2. Chatterjee, A., Pakrashi, S. C. (1991). The treatise on Indian medicinal plants PID. New Delhi: CSIR.
3. Chattopadhyay, S. K., Thakur, R. S., Patnaik, G. K. Shrimal, R. C. (1999). Indian patent, patent no.182638.
4. Chee-Kin, H., George, K. K. (2005). Advances in immunomodulating therapy of HBV infection. Int. J. Med. Sci. 2(1), 24-29.
5. Corbett, J. A., Kwon, G., Turk, J., Mcdanial, M. L. (1993).IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islet of lagerhans: Activation of cyclooxygenase by nitric oxide. Biochemistry 32(50),13767-13770.
6. Cui, S. X., Xie, Y. Y., Xie, Y. Y., Nakata, M., Makuuchi, M. and Tang, W. (2006). Curcumin inhibits telomerase activity in human cancer cell lines. Int. J. Mol. Med. 18(2), 227-31.
7. De Maio, A., de Mooney, M. L., Matesic, L. E., Paidas, C. N., Reeves, R. H.(1998). Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock 10, 319-323.
8. De Souza, J. B., Riley, E. M.(2002). Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infection 4, 291-300.
9. De Waal., Malefyt, R., Abrams, J., Bennett, B. (1991). Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulation role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
10. Goldring, M. B. (1999). The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res. 40, 1-11.
11. Grau, G. E., Taylor, T. E., Molyneux, M. E.(1989). Tumor necrosis factor and disease severity in children with faciparum malaria. N Engl J Med 320, 1586.
12. Hodge, G., Hodge, S., Han, P. (2002). Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease. Cytometry; 48, 209-215.
13. Ialenti, A., Ianaro, A., Moncada, S., Di Rosa, M. (1992). Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol., 211, 177-82.
14. Inaba, R., Sugiura, H., Iwata, H., Mori, H., Tanaka, T. (1996). Immunomodulation by Maharishi Amrit Kalash in mice. J. Appl. Nutr, 48, 10-21.
15. Jeschke, M. G., Wolf, S. E., DebRoy, M. A., Herndon, D. N. (1999). The combination of growth hormone with hepatocyte growth factor alters the acute phase response. Shock 12, 181-187.
16. Jeschke, M. G., Barrow, R. E., Suzuki., F., Rai, J., Benjamin, D., Herndon, D. N. (2002). IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Molecular Medicine 8(5), 238-246.
17. Kajekar, R., Moore, P. K., Brain, S. D.(1995). Essential role for nitric oxide in neurogenic inflammation in rat cutaneous microcirculation; Evidence for an endothelium-independent mechanism. Circ. Res. 76, 441-7.
18. Kim, H. P., Son, K. H., Chang, H. W., Kang, S. S. (2004). Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci,.96(3), 229-45.
19. Kimura, K., Moriwaki, H., Nagaki, M., Saio, M., Nakamoto, Y., Naito, M., Kuwata, K., Chisari, F. V. (2006).Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease. Am J Pathol. 168(3), 786-95.
20. Kurrer, M. O., Kopf, M., Penninger, J. M., Eriksson, U. (2002). Cytokines that regulate autoimmune myocarditis. Swiss Med Wkly 132, 408-13.
21. Kusske, A. M., Rongione, A. J., Reber, H. A.(1996). Cytokines and acute pancreatitis. Gastroenterology, 110, 639-642.
22. Livingston, D. H., Mosenthal, A, C., Deitch, E. A. (1995).Sepsis and multiple organs dysfunction syndrome: a clinical-mechanistic overview. New Horizons. 3, 276-287.
23. Matsumori, A., Ono, K., Nishio, R., Igata, H.,Shioi S., Furukawa Y., Iwasaki, A., Nose, Y., Sasayama, S. (1997). Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain. Circulation, 96(5), 1501-1506.
24. Mayeux, P. R. (1997). Pathobiology of lipopolysaccharide. Journal Toxicology Environmental Health. 51, 415-435.
25. Miller, K. L., Silverman, P. H., Kullgren, B., Mahlmann, L. J. (1989). Tumor necrosis factor alpha and the anemia associated with murine malaria. Infection and Immunity. 57, 1542-1546
26. Nadkararni, K. M., Nadkarani, A. K.(1992). Indian materia medica, vol 1. Bombay: Prakashan, 498.
27. Pinsky, M. R., Vincent, J. L., Deviere, J. (1993). Serum cytokine levels in human septic shock: relation to multiple system organ failure and mortality. Chest. 103, 565-575.
28. Pruitte, J. H., Copeland, E. M., Moldawer., L. L.(1995). Interleukin-1 and interleukin-1 antagonism in sepsis systemic inflammatory response syndrome and septic shock. Shock 3, 35-251.
29. Sang, K. H., Pyeongjae, L., Jeong, A. P. et al. (2008). Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochemistry International. 52(4-5), 878-886
30. Selzman, C. H., Shames, B. D., Miller, S. A.(1998). Therapeutic implications of interleukin-10 in surgical disease. Shock 10, 309-318.
31. Sharma, H. M., Dwivedi, C., Satter, B. C., Gudenithlu, K. P., About-Issa, H., Malarkey, W., Tejwani, G. A.(1990). Antineoplastic properties of MAK-4 against DMBA-induced mammary tumors in rats. Pharmacol Biochem. Behav. 35, 1-7.
32. South, E. H., Exon, J. H., Hendrix, K. (1997). Dietary curcumin enhances antibody response in rats. Immunopharmacol. Immunotoxicol. 19, 105-119.
33. Tanaka, T., Sugiora, H., Inaba, R., Koshimizu, K., Ohigashi, H. (1999). Immunomodulatory action of citrus acuraptene on macrophage-functions and cytokine production of lymphocytes in female BALB/c mice. Carcinogenesis. 20(8), 1471-76.
34. Taverne, J., Sheikh, N., de Souza, J. B. (1994). Anemia and resistance to malariin transgenic mice expressing human tumor necrosis factor. Immunology 82, 397.
35. Wai M. L., Julie M. P., Scott S., Allan, J. M., Paul, W. N., Paul, A. K., Jonathan, M. H., Kevin, D. C. (2008). Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: Lack of association between antioxidant and lipoxygenase inhibitory activity. Biochemical Pharmacology, 75(5), 1045-1053.
36. Williams, G., Giroir, B. (1995). Regulation of cytokine gene expression: tumor-necrosis factor, interleukin-1, and the emerging biology of cytokine receptors. New Horizons 2, 276-287.
37. Yadav, V. S., Mishra, K. P., Singh, D. P., and Singh, V. K. (2005). Immunomodulatory effect of curcumin: Immunopharmacol and Immunotoxicol. 27 (3), 465-97.
38. Zheng, L. T., Jiyeon Ock J., Kwon B. M., Kyoungho, S. (2008). Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. International Immunopharmacology. 8(3), 484-494.